Sites of destruction of red cells in G-6-PD deficient Caucasians and in phenylhydrazine treated patients.
D001803:Blood Transfusion; D002859:Chromium Isotopes; D005260:Female; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000097:blood*; D006400:Hematocrit; D006452:Hemoglobinometry; D006461:Hemolysis; D006801:Humans; D008099:Liver / Q000502:physiology*; D008297:Male; D008433:Mathematics; D008722:Methods; D010659:Phenylhydrazines / Q000627:therapeutic use*; D011087:Polycythemia Vera / Q000188:drug therapy*; D011319:Primaquine / Q000009:adverse effects; D012737:Sex Factors; D013154:Spleen / Q000502:physiology*; D013997:Time Factors; D044465:White People
D002859:Chromium Isotopes; D010659:Phenylhydrazines; D011319:Primaquine